Emcure Pharmaceuticals (NSE:EMCURE) Change In Receivables : ₹0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Emcure Pharmaceuticals Change In Receivables?

Emcure Pharmaceuticals's change in receivables for the quarter that ended in Mar. 2025 was ₹0 Mil. It means Emcure Pharmaceuticals's Accounts Receivable stayed the same from Dec. 2024 to Mar. 2025 .

Emcure Pharmaceuticals's change in receivables for the fiscal year that ended in Mar. 2025 was ₹-1,434 Mil. It means Emcure Pharmaceuticals's Accounts Receivable increased by ₹1,434 Mil from Mar. 2024 to Mar. 2025 .

Emcure Pharmaceuticals's Accounts Receivable for the quarter that ended in Mar. 2025 was ₹20,022 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Emcure Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2025 was 86.33.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Emcure Pharmaceuticals's liquidation value for the three months ended in Mar. 2025 was ₹-8,297 Mil.

Emcure Pharmaceuticals Change In Receivables Historical Data

The historical data trend for Emcure Pharmaceuticals's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Emcure Pharmaceuticals Change In Receivables Chart

Emcure Pharmaceuticals Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Mar25

Change In Receivables

-3,301.48

-1,728.71

-3,397.94

-1,506.03

-1,434.39

Emcure Pharmaceuticals Quarterly Data
	Mar21	Mar22	Mar23	Sep23	Dec23	Mar24	Sep24	Dec24	Mar25
Change In Receivables	Get a 7-Day Free Trial				-	-	-	-	-

Emcure Pharmaceuticals Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Emcure Pharmaceuticals (NSE:EMCURE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Emcure Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	20022.43	/	21162.45	*	91
=	86.33

2. In Ben Graham's calculation of liquidation value, Emcure Pharmaceuticals's accounts receivable are only considered to be worth 75% of book value:

Emcure Pharmaceuticals's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	2938.61	-	35911.69	+	0.75 * 20022.43	+	0.5 * 19318.12
=	-8,297

Emcure Pharmaceuticals Change In Receivables Related Terms

Thank you for viewing the detailed overview of Emcure Pharmaceuticals's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Emcure Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Emcure Pharmaceuticals Ltd (NSE:EMCURE) » Definitions » Change In Receivables

Traded in Other Exchanges

544210:India

Address

Plot No. P-1 and P-2, IT-BT Park, Phase II, M.I.D.C., Hinjawadi, Hinjawadi, MH, IND, 411057

Website

https://www.emcure.com

Emcure Pharmaceuticals Ltd an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a range of pharmaceutical products across several therapeutic areas. Its portfolio includes orals including solids, liquid orals and dry syrup/suspensions., injectables such as vials and pre-filled syringes, and forms such as lyophilized & liquid and biotherapeutics.

Emcure Pharmaceuticals Headlines

No Headlines